1-17028628-T-G
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_003000.3(SDHB):c.395A>C(p.His132Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H132R) has been classified as Uncertain significance.
Frequency
Consequence
NM_003000.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Pheochromocytoma;C0238198:Gastrointestinal stromal tumor;C1861848:Paragangliomas 4 Pathogenic:1
ClinVar contains an entry for this variant (Variation ID: 12787). This sequence change replaces histidine with proline at codon 132 of the SDHB protein (p.His132Pro). The histidine residue is highly conserved and there is a moderate physicochemical difference between histidine and proline. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individuals with clinical features of SDHB-related conditions (PMID: 14715873, 31492822). It has also been observed to segregate with disease in related individuals. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SDHB protein function. For these reasons, this variant has been classified as Pathogenic. -
Paragangliomas 4 Pathogenic:1
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.H132P variant (also known as c.395A>C), located in coding exon 4 of the SDHB gene, results from an A to C substitution at nucleotide position 395. The histidine at codon 132 is replaced by proline, an amino acid with similar properties. This alteration was reported in two siblings diagnosed with PGL at ages 25 and 53; both tumors exhibited LOH, and RT-PCR expression analysis confirmed that p.H132P was the only expressed allele in the tumors (Maier-Woelfle M et al. J. Clin. Endocrinol. Metab., 2004 Jan;89:362-7). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at